Park Ha Biological Technology (BYAH) Income Statement (2022 - 2024)
Annual Income Statement report data from Oct 31, 2022 to Oct 31, 2024 for Park Ha Biological Technology (BYAH).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2024 | 2023 | 2022 | |
|---|---|---|---|
Revenue and COGS | |||
Total Revenue | 2.38M (-3.25%) | 2.46M (+28.13%) | 1.92M |
Cost Of Revenue | 200K (-35.48%) | 310K (-39.22%) | 510K |
Costof Goods And Services Sold | 200K (-35.48%) | 310K (-39.22%) | 510K |
Gross Profit | 2.19M (+1.86%) | 2.15M (+52.48%) | 1.41M |
Operating Expenses | |||
Research And Development | 40K (+33.33%) | 30K (-50.00%) | 60K |
Selling General And Administrative | 810K (+68.75%) | 480K (-32.39%) | 710K |
Operating Expenses | 1.39M (+43.30%) | 970K (-19.83%) | 1.21M |
Depreciation And Amortization | 20K (0.00%) | 20K (-33.33%) | 30K |
Operating Income | |||
Operating Income | 790K (-33.05%) | 1.18M (+490.00%) | 200K |
Ebit | 790K (-33.05%) | 1.18M (+490.00%) | 200K |
EBITDA | 820K (-31.67%) | 1.20M (+421.74%) | 230K |
Other Income / Expenses | |||
Other Non Operating Income | - | - | -10.00K |
Net Income | |||
Income Before Tax | 790K (-33.05%) | 1.18M (+521.05%) | 190K |
Income Tax Expense | 310K (-6.06%) | 330K | - |
Net Income From Continuing Operations | 480K (-43.53%) | 850K (+347.37%) | 190K |
Net Income | 480K (-43.53%) | 850K (+347.37%) | 190K |
Comprehensive Income Net Of Tax | 490K (-40.24%) | 820K (+331.58%) | 190K |